Article abstract
Nature Medicine 13, 1060 - 1069 (2007)
Published online: 12 August 2007 | doi:10.1038/nm1621
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
Liyong Zhang1,2,5, Michael S Anglesio3,5, Maureen O'Sullivan3, Fan Zhang3, Ge Yang2, Renu Sarao1,2, Mai P Nghiem1,2, Shane Cronin1, Hiromitsu Hara1, Nataliya Melnyk3, Liheng Li3, Teiji Wada1, Peter P Liu2, Jason Farrar4, Robert J Arceci4, Poul H Sorensen3 & Josef M Penninger1
Abstract
Transformation and cancer growth are regulated by the coordinate actions of oncogenes and tumor suppressors. Here, we show that the novel E3 ubiquitin ligase HACE1 is frequently downregulated in human tumors and maps to a region of chromosome 6q21 implicated in multiple human cancers. Genetic inactivation of HACE1 in mice results in the development of spontaneous, late-onset cancer. A second hit from either environmental triggers or genetic heterozygosity of another tumor suppressor, p53, markedly increased tumor incidence in a Hace1-deficient background. Re-expression of HACE1 in human tumor cells directly abrogates in vitro and in vivo tumor growth, whereas downregulation of HACE1 via siRNA allows non-tumorigenic human cells to form tumors in vivo. Mechanistically, the tumor-suppressor function of HACE1 is dependent on its E3 ligase activity and HACE1 controls adhesion-dependent growth and cell cycle progression during cell stress through degradation of cyclin D1. Thus, HACE1 is a candidate chromosome 6q21 tumor-suppressor gene involved in multiple cancers.
- Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohrgasse 3, 1030 Vienna, Austria.
- Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto and Toronto General Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
- British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z1L3, Canada.
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21231, USA.
- These authors contributed equally to this work.
Correspondence to: Poul H Sorensen3 e-mail: psor@interchange.ubc.ca
Correspondence to: Josef M Penninger1 e-mail: josef.penninger@imba.oeaw.ac.at
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesisOncogene Original Article
Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesisOncogene Original Article
Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomasNature Medicine Article (01 Jan 2000)
See all 17 matches for Research
